Midatech Pharma Share Price (MTPH)

Show Chart Filters
Time period:
Moving Average:
Compare to:
Price 6.00on 18-10-2019 at 16:30:00
Change 0.00 0.00%
Buy 6.25
Sell 5.75
Buy / Sell MTPH Shares
Sponsored Financial Content
Last Trade: Buy 250,000 at 6.05p
Day's Volume: 875,782
Last Close: 6.00p
Open: 6.00p
ISIN: GB00BRTL9B63
Day's Range 6.00p - 6.00p
52wk Range: 2.55p - 18.00p
Market Capitalisation: £25m
VWAP: 0.00p
Shares in Issue: 410m

Recent Trades History Midatech Pharma (MTPH)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy*250,0006.05Ordinary
15:21:17 - 18-Oct-19
Buy*250,0006.05Ordinary
15:20:43 - 18-Oct-19
Buy*130,0816.15Ordinary
15:07:55 - 18-Oct-19
Unknown*25,0006.00Uncrossing Trade
14:00:12 - 18-Oct-19
Buy*75,0006.156Ordinary
10:37:48 - 18-Oct-19
Buy*75,0006.125Ordinary
10:33:46 - 18-Oct-19
Sell*13,4605.75Ordinary
09:34:02 - 18-Oct-19
Sell*40,0005.915Ordinary
09:16:38 - 18-Oct-19
Sell*17,2415.95Ordinary
08:43:34 - 18-Oct-19
Buy*-80,5166.20Ordinary
Deletion
Delayed publication
Historical
14:31:20 - 17-Oct-19

Share Price History for Midatech Pharma

Time period:
to
Date Open High Low Close
17th Oct 2019 (Thu)5.3756.1255.3756.00
16th Oct 2019 (Wed)5.255.3755.005.375
15th Oct 2019 (Tue)5.755.755.3755.375
14th Oct 2019 (Mon)6.1255.905.905.875
11th Oct 2019 (Fri)6.256.006.006.125
10th Oct 2019 (Thu)6.256.256.256.25
9th Oct 2019 (Wed)6.1256.256.1256.25
8th Oct 2019 (Tue)6.256.256.1256.125
7th Oct 2019 (Mon)6.256.256.1256.125
4th Oct 2019 (Fri)5.8756.3755.8756.25
3rd Oct 2019 (Thu)5.6255.8755.6255.875
2nd Oct 2019 (Wed)5.3755.6255.3755.625
1st Oct 2019 (Tue)5.255.255.255.25
30th Sep 2019 (Mon)5.1255.255.1255.125
27th Sep 2019 (Fri)5.1255.255.1255.25
26th Sep 2019 (Thu)5.1255.1255.1255.125
25th Sep 2019 (Wed)5.1255.1255.005.125
24th Sep 2019 (Tue)5.755.755.1255.125
23rd Sep 2019 (Mon)5.755.755.705.75
20th Sep 2019 (Fri)5.756.405.755.75

News about Midatech Pharma (MTPH)

Midatech Pharma wins approval to commence tumour treatment study

News - Friday, September 20, 2019

Midatech Pharma said it had received approval to commence a study of a treatment for acromegaly and neuroendocrine tumours. The Phase 1 study would test its treatment candidate MTD201 and investigate subcutaneous administration as an additional injection route, compared to intramuscular administration. It would be conducted in 28 healthy subjects, with data expected to become available towards the end of 2019 or early in 2020. The objective was to determine the administration route for the pivotal registration study to be commenced in 2020. At 8:31am: (LON:MTPH) Midatech Pharma Plc share price was +0.83p at 6.2p Story provided by StockMarketWire.com. ...

Midatech Pharma gets €6.6m grant from Spanish government

News - Wednesday, September 11, 2019

Oncology and rare disease focused Midatech Pharma said it had received funding of €6.6m from the Spanish government. The funding would support the company' manufacturing facility in Bilbao. It brought the total public financing available for this project to up to €8.5m, including previous grant and loan amounts recently approved by the Basque regional government. The total manufacturing cost of the project was currently estimated at about €16m, subject to finalisation of a manufacturing strategy. At 1:49pm: (LON:MTPH) Midatech Pharma Plc share price was +1p at 6.25p Story provided by StockMarketWire.com. ...

FTSE 100 Latest
Value7,150.57
Change-31.75


Login to your account

Forgot Password?

Not Registered